Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Bone Marrow Transplantation
|
November 1, 1996
Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry
F Locatelli, M Zecca, C Niemeyer, et al.
British Journal of Haematology
|
June 8, 2004
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia
J R Passweg, M Rabusin, M Musso, et al.
Leukemia
|
November 26, 2013
miR-9 is a tumor suppressor in pediatric AML with t(8;21)
S Emmrich, J E Katsman-Kuipers, K Henke, et al.
Leukemia
|
September 24, 2010
High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome
B V Balgobind, C M Zwaan, D Reinhardt, et al.
Leukemia
|
June 29, 2013
The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS
A M Aalbers, V H J van der Velden, A Yoshimi, et al.
Leukemia
|
April 2, 2010
EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia
B V Balgobind, S Lugthart, I H Hollink, et al.
Leukemia
|
March 16, 2013
Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood
A M Aalbers, M M van den Heuvel-Eibrink, V de Haas, et al.
Blood Cancer Journal
|
May 3, 2014
T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS
A M Aalbers, M M van den Heuvel-Eibrink, I Baumann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 17, 2021
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol
J Stutterheim, P de Lorenzo, I M van der Sluis, et al.
Leukemia
|
December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008
M Brüggemann, A Schrauder, T Raff, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Bone Marrow Transplantation
|
November 1, 1996
Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry
F Locatelli, M Zecca, C Niemeyer, et al.
British Journal of Haematology
|
June 8, 2004
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia
J R Passweg, M Rabusin, M Musso, et al.
Leukemia
|
November 26, 2013
miR-9 is a tumor suppressor in pediatric AML with t(8;21)
S Emmrich, J E Katsman-Kuipers, K Henke, et al.
Leukemia
|
September 24, 2010
High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome
B V Balgobind, C M Zwaan, D Reinhardt, et al.
Leukemia
|
June 29, 2013
The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS
A M Aalbers, V H J van der Velden, A Yoshimi, et al.
Leukemia
|
April 2, 2010
EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia
B V Balgobind, S Lugthart, I H Hollink, et al.
Leukemia
|
March 16, 2013
Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood
A M Aalbers, M M van den Heuvel-Eibrink, V de Haas, et al.
Blood Cancer Journal
|
May 3, 2014
T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS
A M Aalbers, M M van den Heuvel-Eibrink, I Baumann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 17, 2021
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol
J Stutterheim, P de Lorenzo, I M van der Sluis, et al.
Leukemia
|
December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008
M Brüggemann, A Schrauder, T Raff, et al.
Page
of 7